Digital health innovations
We are actively seeking proven digital innovations that improve the health of people in the region and raise the quality, efficiency, safety and cost-effectiveness of delivering healthcare.
We are particularly interested to hear about innovations in the following categories:
  • Health maintenance - supporting people in maintaining their physical and mental wellbeing,
  • Prevention - alerting patients, carers or professionals when there are signs that things aren’t going well, and an intervention can prevent crises or emergencies
  • Access - providing more convenient and cost-effective ways for patients and professionals to interact. (e.g. remote monitoring or virtual consultations).
  • Learning and education - delivering information and knowledge to patients about their health or condition, or to professionals to support their continuous professional development
  • Pathways - providing tailored information to patients, carers and professionals on services to signpost people to the most appropriate place.  Ideally, this could be enhanced with real-time information about capacity.
  • Research - using digital tools to promote involvement in research & clinical trials, to streamline the capture of informed consent, and to capture research data more efficiently and conveniently.
  • Integration - tools that enable the secure, appropriate sharing of information between organisations (e.g. GPs and hospital clinicians) and sectors (e.g. NHS and Social Services) to allow patients to receive seamless care.
  • Data Visualisation - innovative ways of presenting information in a meaningful way to enable more informed decisions by patients and professionals.  This may involve aggregating data from different sources, reporting tools or graphic visualisations such as heat maps.

Ideas (Publish, Detailed Submission)

Innovation 'Elevator Pitch':
SMC provides an innovative, integrated, digital platform solution that deliver better patient outcomes, greater self-management and delivers healthcare more efficiently. The system is highly configurable and customisable and deployable at scale.
Overview of Innovation:
SPS have created an open, future proofed digital platform that harnesses and integrates a range of mobile, communication and wearable technologies to pre-emptively and pro-actively support improved patient outcomes while enabling more efficient healthcare service delivery across primary, secondary and social care environments.
Our mobile health (mHealth), telemedicine and telecoaching solutions use familiar mobile and ‘cloud’ based technology. It has been proven to  support service redesign and deliver more efficient, patient centric healthcare that’s cost effective, simple to use and easy to implement at scale.
Our ‘open’ architecture and web based platform enables more holistic Long Term Condition management services by leveraging a range of technologies across mobile, tablet, text, video and voice to deliver a highly flexible solution for healthcare professionals and patients. Mobile health (mHealth) enhances patient outcomes by enabling clinicians to pro-actively and pre-emptively monitor patients remotely while also enabling the individual to better understand and manage their condition that results in improved patient outcomes, reduced visits to hospital and local GP’s Surgeries.
Our SMCTM solution can be customised to meet any Long Term Condition (LTC), co-morbidity or medical condition that an individual may suffer from. It can support one or multiple LTCs, as well as any other health or mental health condition where a question or vital sign measurement can be of benefit. To date core commissioning has been focused on supporting people who suffer from Heart Failure, Coronary Heart Disease, Hypertension, Chronic Obstructive Pulmonary Disease, Asthma and Diabetes, but we have also developed profiles to support Urinary Tract Infection, Falls Prevention, Dementia and Depression management, Cystic Fibrosis, Obesity and end of Life.
The SMCTM solution is deployed across multiple CCG’s and provider in the UK with over 10,000 patients benefiting from the system over the past 5 years. We have supported different operational and clinical pathways, including effective system deployment into patient homes and Care Home environments that can then enable pro-active and pre-emptive alerts to be raised with a Clinical care team.  Our technology and services have also been selected by a wide range of organisations including BT Health, Alere, Welch Allyn, MSD Commercial, Healthcare @Home to support new and existing service models in the field of telehealth.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Key deliverables achieved with SMCTM solution:
  • Facilitate early patient discharge and reduce bed days: Harrow CCG, 2014: achieved a 50% reduction in unplanned admissions and 63% bed day reduction to deliver an ROI of 159% and net savings of £3,444 per COPD and cardiac patients.
  • Improve prevention and early intervention:  Derbyshire Community Hospital, 2014: achieved a 68% reduction in unplanned admissions; 415 bed day reduction across 187 patients in a 6 month period with a net saving of c£100,000.
  • Improve service value and efficiency of service provider: Bristol CCG, 2013: within just 30days of the telehealth service starting the number of contacts reduced by 26% with an 18% reduction in face to face time and 40% reduction in telephone contacts
  • Sustain independent living and improve patient outcomes: Birmingham Community Health, 2014: Surveyed 312 patients with 86% of patients stating system helped them manage their condition; 84% more involved in their care; 90% happy to reduce the number of routine hospital visits.
     
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
SMC offers multiple benefits for patients:
  • Personalised care modules: supports an individual's care needs using the most relevant questionnaires, vital signs and content.
  • Embedded educational content: on demand video aids training, behaviour change, understanding and the confidence for patients to self-manage their condition.
  • Sustains independent living: the use of relevant, integrated and familiar technology empowers patients to better understand and manage their conditions at home.
  • Easy to use and "out of the box": use fo familiar smartphones and tablets with wireless peripherals; audio and multi-lingual options.
  • Remote access and support software: touchscreeen enabled device support over the phone.
  • Video tele-consultation: remote "face to face" clinical consultation to aid better clinical intervention.
  • Text messaging: enable cost effective self-care.
  • Better patient outcomes: improves quality of life, reduces anxiety and increases confidence.
Current and planned activity: 
The SMC solution is deployed across multiple CCG’s and provider in the UK with over 10,000 patients benefiting from the system over the past 5 years. We have supported different operational and clinical pathways, including effective system deployment into patient homes and Care Home environments that can then enable pro-active and pre-emptive alerts to be raised with a Clinical care team.   Our technology and services have also been selected by a wide range of organisations including BT Health, Alere, Welch Allyn, MSD Commercial, Healthcare @Home to support new and existing service models in the field of telehealth.
We have long standing partnerships with Somerset CCG, Cornwall Foundation Trust Rotherham NHS Foundation Trust, and Dudley CCG and have been awarded innovator partnership on two Test Beds, one in Surrey and one in Manchester (with MSD Commercial.)

We support other conditions and pathways: Cystic Fibrosis, Falls and UTI, Spina Bifida children, LTC6 and E5QD quality of life.
Return on Investment (£ Value): 
N/A
Return on Investment (Timescale): 
N/A
Ease of scalability: 
Simple
Read more
Hide details
Elisabeth Barbosa 12/01/2017 - 17:57 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
GroundVision provides the next generation of patient observations, and a range of dashboards, including our specialised Rapid Detection and Response (RADAR) view, to enable an efficient, proactive response to the deteriorating patient.
Overview of Innovation:
Over 6,000 people die every year in hospital as a result of “failing to rescue” a deteriorating patient. GroundVision provides a simple and cost effective system to record and calculate EWS (Early Warning Score) and a variety of other observations and assessments, from Bristol Stool to Fluid Balance, at the patient bedside to ensure that deteriorating patients are quickly and accurately identified.

As well as the ability to record patient observations at the bedside, GroundVision provides a variety of specialised views for different departments of a hospital:

Ward View
Displays information and observations about all patients on a ward.
 
Critical Care View
Displays information and observations about all patients in the Trust, with filtering capabilities, enabling searches for groups of patients (e.g. those that are deteriorating).
 
Infection Control View
Displays information about Bristol Stool Samples and infectious patients, enabling better control of infection outbreaks.
 
Ops Team View
Displays all side rooms in the hospital, with information about their occupancy, including a reason and priority for the isolation of a patient.
 
Dashboard View
Allows users to create customisable reports/graphs about a wide range of patient and observation related information.
 
RADAR (Rapid Detection And Response) View
Provides a view that shows all deterioration patients within their “score banding” who have not been responded to. The solution also graphically shows their health trajectory enabling healthcare staff to intervene before the patient triggers. This real-time view can be displayed via tablet, desktop or electronic whiteboard onsite or remotely.

Our solution has been developed alongside nurses, so it is easy to use as well as being low cost. It can be used on any device and accessed remotely as well as on site.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Patient and medicines safety / Person centred care
Benefit to NHS:
GroundVision can provide a variety of benefits to the NHS:
  • Reduction in patient mortality
  • Reduction in hospital length-of-stay
  • Reduction in time taken to record/calculate Obs/EWS
  • Improvement in the accuracy of EWS calculations
  • Increased levels of clinical attendance
  • Increase compliance with hospital protocols
  • Reduction in the number of unexpected cardiac arrests
  • Fewer admissions to ICU
  • Reduction in the number of ICU days
  • Reduction in the number of infection outbreaks
As well as this, it brings the NHS one step closer to being paperless.
Initial Review Rating
3.80 (1 ratings)
Benefit to WM population:
It can help NHS organisations within the West Midlands area by improving patients safety and patient outcomes.
Current and planned activity: 
We have been engaged with Surrey and Sussex Healthcare NHS Trust, co-developing our solution alongside them and providing pilot projects, rolling out our solution to several wards.

We are also currently engaged with other NHS organisations within that area, such as Kent Community Healthcare NHS Foundation Trust.

We will continue to engage with as many NHS organisations as we can as well as continuing to develop our solution, to increase the wealth of observations and assessments that we have available to contribute towards improving patient safety.
What is the intellectual property status of your innovation?:
Simply Clever Ltd (trading as GroundVision) own the intellectual property 100%
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
3 years +
Ease of scalability: 
2
Read more
Hide details
Anonymous 12/01/2017 - 17:24 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
More people die of SUDEP (Sudden Unexpected Death in Epilepsy) than in house fires every year.
 
Every home has smoke detector, so why shouldn’t all epileptics have a device that alerts people close by so that they can provide assistance when needed?
Overview of Innovation:
Embrace is the world’s 1st system for seizure detection based on analysing multiple physiological data sensed at the wrist.



Should someone with Epilepsy experience an ‘unusual event’, such as a convulsive seizure, an alert will be sent via their smartphone to parents, friends or caregivers, summoning immediate help. Additionally, a caregiver can also wear a 'companion' Embrace. When the two Embraces are within range (e.g. in nearby rooms), the 'companion' Embrace worn by the caregivers will vibrate to alert them.

The Embrace watch has received awards for its design & innovative technology. The watch monitors Electrodermal Activity (EDA), also known as Galvanic Skin Response (GSR), which is autonomic data that is activated by regions deep in the brain involved in emotions such as fear, anxiety & excitement.
 
Embrace watch also functions as a sleep monitoring & activity tracking device.
 
What else do Embrace sensors monitor?
Embrace comes with an app called Mate. Mate combines events that are entered manually with events that are sensed by Embrace. Mate helps see how patterns of sleep, autonomic stress, skin temperature and physical activity may interact with seizure events. (NB: initial release of Mate app features rest and activity information, while features like autonomic stress monitoring, are still in development and will be added later). For example, if there are an increased number of absence seizures when stress levels have been high and sleep has been irregular, then these can be tracked to see if changing these patterns reduces the number of seizures.
 
Embrace and Alert app system for seizure detection is for investigational use only. The system is currently not clinically proven to detect seizures. Evidence of seizure characterization using the technology in Embrace has been gathered in a number of clinical trials since the initial discovery of skin conductance changes during a seizure was published in 2012. Empatica is currently conducting clinical trials to evaluate seizure detection of generalised tonic clonic seizures (GTCS) using the Embrace watch & Empatica Alert app.
 
The automatic physiological data logging provided by the Embrace system is valuable when someone experiences a seizure as they may not remember what has happened themselves. A diagnosis is often based on finding out what happened to the individual before, during and after a seizure.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
The number of people in the UK diagnosed with epilepsy has risen sharply in recent years. There are around 65 million people living with epilepsy in the world, with an estimated 600,000 people in the UK.
 
Every day in the UK, 87 people are diagnosed with epilepsy. Only 52% people with epilepsy in the UK are seizure-free.
 
During 2013, 1,187 people in the UK with epilepsy died earlier than expected (premature death). Some of these deaths could have been prevented. A clinical audit of epilepsy deaths in 2002 found that 64 per cent of adult deaths and over half of child deaths were possibly or probably avoidable.
 
Epilepsy is misdiagnosed in 20-30% of cases: most commonly, non-epileptic conditions are incorrectly diagnosed as epilepsy. Up to 40% of children referred to a tertiary clinic do not have epilepsy.  In 2004, the National Institute for Clinical Excellence (NICE) estimated the direct costs of epilepsy misdiagnosis (including inappropriate treatment, but not including individuals’ lost productivity from misdiagnosis) to be between £130m and £190m per year (NICE (2004) Epilepsy, second consultation, Appendix G).
 
Limiting the rate of misdiagnosis will help to reduce the risk of teratogenicity in wrongly diagnosed patients and will prevent patients wrongly diagnosed with epilepsy from facing, for example, unnecessary restrictions in employment and in other areas of life. Better diagnostic services are also likely to reduce any treatment gaps or inequalities, and, through encouraging independent living, improve the rate of employability for people with epilepsy. Finally, patients will have a greater choice of treatment options and a greater sense of empowerment
 
Epilepsy is an ambulatory-sensitive condition, meaning that better management in the community or primary care setting can effectively avoid unnecessary visits to the emergency department and non-elective hospital admissions.
 
Prevention of 15 admissions to hospital would Save the salary of a single epilepsy nurse
Estimate from National Audit of Seizure Management in Hospitals 2 (NASH2)
 
In 2009, there were 13 million prescription items of anti-epileptic drugs dispensed in the community in England, at a net ingredient cost of £300 million (NHS Information Centre Prescription Cost Analysis 2009. The net ingredient cost is the cost of the drug before discounts, not including any dispensing costs of fees).
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
Epilepsy affects 54,000 people in the West Midlands (Source Birmingham City Council May 2016). The economic and social costs of managing this cohort is very significant.
 
Gaining control of one’s epilepsy not only saves direct health related costs in terms of fewer emergency or longer term hospital admissions, but also enables individuals with epilepsy to continue working and maintain their independence.
Current and planned activity: 
Current activity:
The Embrace device was only recently launched in the UK in November 2016. Currently clinical trials are taking place in the USA.
https://support.empatica.com/hc/en-us/sections/200817625-Seizure-Characterization-Clinical-Trial-monitoring-with-Embrace
 
We have taken orders from a number of Local Authority Assistive technology departments and are keen to engage further with the NHS.

Planned/future activity:
The published trial results cited above were from predicate devices. We need to collect more data using the Embrace and Alert app to complete the medical and FDA certification processes before we are able to make any claims regarding seizure detection performance of this system.
 
We are very keen to work more closely with any West Midlands network that provides support to people with Epilepsy or Autism.
 
What is the intellectual property status of your innovation?:
Patents Held by Empatica – further info available upon request.

The device is currently being fast tracked through FDA approval.

It also holds - Certifications:  CE Mark, FCC CFR 47 Part 15,  RoHS.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Ben Carter 19/12/2016 - 13:34 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Medelinked is a secure mobile and online health platform that empowers you to take control of your health and sharing your health and wellness information with your trusted healthcare providers.  
Overview of Innovation:
Medelinked is leveraging mobile technology and the cloud, aiming to increase health care efficiency and effectiveness. Medelinked Health Cloud and API is the leading platform already powering some of the best mHealth applications allowing developers to create a series of new applications that deliver real health benefits to the end user and healthcare professionals. 
Using Medelinked, individuals are able to create a health profile online that is secure and connect and share their health record with their network of trusted health partners and providers (including doctors, dentists, physiotherapists, trainers, insurers, clinical researchers). Managing all their health data in one place helps individuals securely track and monitor improvements easier and quicker and share vital data with their healthcare providers to ensure they have access to their latest health data. This enables them to provide the best possible care and it keeps the individual in control of their own health.
Medelinked Account Features:
  1. Add key personal details and list medical conditions, medications, allergies and vaccinations, together with your next of kin details
  2. Add contact details for all the important health professionals you interact with in order to communicate directly with your GP, receive health advice in real time and chat by secure email, voice, text, video and instant messaging.
  3. Create an emergency record that can then be accessed by emergency first responders with its needed most
  4. Upload and store scans, x-rays and other medical reports and test results
  5. Connect your health devices (smartwatches, fitness trackers, blood pressure monitors and blood glucose monitors) to enable seamless streaming of data into your account. Set alerts, monitor and share progress with your support network
The benefits of a Medelinked account is that it allows the patient record to travel with the patient and with this innovation a number of benefits follow. We anticipate better clinical outcomes, greater co-ordination, fewer adverse incidents and cost savings for the NHS as a result of better adherence and compliance with drug regimes, early recognition of signs of illness and increased patient engagement. 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Person centred care
Benefit to NHS:
Cost savings will be derived via better adherence and compliance with drug regimes, greater awareness of health status through inputted data, early identification of illness, ease of communication with health professionals.
Medelinked helps meet the requirements of the accessible information standard and enables a paperless NHS.
Initial Review Rating
5.00 (2 ratings)
Benefit to WM population:
Medelinked information sharing approach restores trust by placing control in the hands of the consumer.
Managing health data all in one place helps individuals securely trace, monitor and improve their health state, ensuring their latest health data is accessed and enabling the provision of best possible care,
Personal health records allows the patient record to travel with the patient, allowing better clinical outcomes and fewer adverse incidents.
Current and planned activity: 
Medelinked to date has not tried to work with the NHS. The companies focus has been to work with private health insurers and to offer a free to the consumer platform. We know that many consumers are now using Medelinked and asking to link to NHS suppliers. We would like to break down this barrier for our users. 
What is the intellectual property status of your innovation?:
Owned by Medelinked 
About us
Since 2005 Medelinked (previously Zaptag) has been delivering a range of solutions for building, connecting and sharing personal health information. We currently deliver solutions for private health insurers like Aviva, Simply Health and IntegraGlobal. Our open platform and partner approach allows us to deliver bespoke white labelled solutions. Major integrated partners also include Salesforce, FitBit, BioClinica, Allscripts and Jawbone.

Medelinked is based in Oxfordshire, UK. 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Mary Wilson 08/11/2016 - 16:03 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
MyHomeReach is a digital platform that addresses Isolation, Medication Adherence, Chronic Disease Mngt and Maintenance of living environment. It provides personalized services key for the individual while delivering efficiencies to the care giver.
Overview of Innovation:
People want to age in the familiarity of their own homes. They want to continue with their daily routines while maintaining their independence in a safe and secure environment, in a way that contributes to their well-being and quality of life.
MyHomeReach™ enables independence with the reassurance that family, friends, and health care professionals are only one touch away, reducing stress and concern of isolation. This unique solution makes it easy, affordable, and convenient to connect a care recipient with their community i.e. care professionals, family members and social services.
Both formal and informal care givers are able to continuously interact, monitor wellness, record service, and react to alerts. Anyone that is important as a ‘care provider’ can be included in the community of care.
MyHomeReach™ enhances independent living with the comfort that assistance is only a touch away
Desktop/Tablet Application:
MyHomeReach™ makes it easy to manage calendars, share important information. The important resources, services, and community connections you need to age at home in a safe and secure environment are unified in this revolutionary approach to empowering independent living.
MyHomeReach™ simplifies connection to the network of care, medication & appointment reminders and the co-ordinating of schedules.
 
The Mobile Application:
MyHomeReach™ is also available on the go for Care Recipient and CARER via smartphone. In addition to the standard features the phone will have Personal Emergency Response (PERS) capability. Being lost, isolated or confused just press HELP. MyHomeReach™ will raise an alert and send details of your location making it easier and quicker for assistance to be received.
Connect with credentialed service providers so that seniors living independently have a trusted community-vetted resource for transportation, home improvement and service, plumbing, electricians, grocery delivery and other daily assistance
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Improved more efficeny delivery of service; 
•Reduced reliance on manual processes, with increased secure and robust automation of information collection, sharing and analysis to free up resources.
•Streamlining offices processes allowing more focus on client care
Initial Review Rating
3.80 (1 ratings)
Benefit to WM population:
Improved client experience;
•Clients will become active participants in their health care journey and be better informed on their treatment options which increases their engagement and understanding of their care
•Family and Friends engaged
•Ensuring better carer / client matches
•Ensure client concerns are heard and issues resolved via a quality tracking system
Current and planned activity: 
No current engagement with NHS
What is the intellectual property status of your innovation?:
There is no IP
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
Paul Mooney 26/09/2016 - 16:59 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
The Sound Doctor has over 250 high quality short educational films. Evaluations show they work by changing behaviours and improving outcomes to help people get the best out of life with long term conditions. 
Overview of Innovation:
The Sound Doctor is the leading provider of film and audio content for patients in the UK. Our content is thought to be unmatched in quality, range and production values and evaluations show it works by changing behaviours.and improving outcomes to help people get the best out of life with long term conditions.
 
Our films are endorsed by leading charities and adhere to NICE guidelines.
Conditions covered are COPD, Diabetes, back pain, dementia and weight management surgery.  A large series on heart conditions including cholesterol and hypertension, will be made shortly. 
There are over 250 films in our library so far and it is constantly growing.
We also create animations. We have a range of health and wellness short animations which are now being used in pharmacies and GP surgeries around the country. 
In addition, the team also devised and produce Health Today, a national radio programme for NHS England – nhs.uk/healthtodayradio
 
We have evidence that patients with diabetes, for example, have changed their attitudes towards diet and exercise as a result of watching our films. People with COPD are more confident about dealing with exacerbations at home. We also know that across all conditions they are considered a valuable part of people’s health care and improve patient experience.
 
The aims of The Sound Doctor, and there is evidence of this as well, are:
 
1. To reduce the number of avoidable admissions (and readmissions) to hospital
2. To reduce the need for face to face contact with consultants, physicians, nurses, physiotherapists and others (and to improve the quality of meetings which do take place)
3. To address the issue of co-morbidities by creating a multi-condition library
4. To improve medicines management and compliance with medications
5. To improve the quality of care for patients (and patient experience of their care)
6. To help people get the most out of life through effective self-management
   
About us:
The Sound Doctor was founded by Dominic Arkwright and Rosie Runciman and is a registered social enterprise.
Dominic worked as a reporter at the BBC for more than 20 years, mostly on Radio 4 's Today Programme as well as Newsnight and PM. He also presented discussion programme 'Off the Page' and 'The Call' on Radio 4.
Rosie Runciman also worked at the BBC for more than 20 years on Radio 4's Today programme, Newsnight, Radio 5 Live and at The World Service. She was Editor of Newshour and Assistant Editor at Five Live.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
  • For clinicians 
    • Complements and supports sessions
    • Sessions more focused and efficient to achieve better health outcomes
    • Reduces appointments, admissions and DNAs
  • For providers 
    • More efficient caseloads, better outcomes for patients, reduced waiting lists
    • Money saved through reduced numbers of GP appointments, hospital admissions and DNAs
Return On Investment (GPs)
Cost of TSD per patient per annum = £5.00
 
Average number of GP visits pre TSD = 3.7 appointments Average number of GP visits post TSD = 0.42 appointments
 
3 fewer appointments per TSD user x payment for each appointment of
£23.50 (NHS tariffs) = £70.50 per patient; an ROI of 1:14
 
Average number of GP DNAs pre TSD = 2.5 appointments Average number of GP DNAs post TSD = 0.5 appointments
 
2 fewer DNAs per TSD user x cost of each DNA of £36 (Kings Fund) = £72 per patient; an ROI of 1:14
Initial Review Rating
3.80 (1 ratings)
Benefit to WM population:
Benefits for patients
  
  • Empowers and encourages people’s engagement with their condition
  
  • Improves medicines adherence
  
  • Improves overall quality of care
  
  • Improves people’s experience of and satisafaction with their care
Current and planned activity: 
Who’s using The Sound Doctor
•  CCGs 
  • Barnsley, Gloucestershire, West Leicester, Wirral, Newcastle, Central London Community Health Trust
  
  • Hospital Trusts 
    • Guy’s and Tommy’s NHS Trust
    • Liverpool Heart and Chest Hospital
  
  • Other 
    • Philips Healthcare
    • All South London pharmacies
    • Jhoots Pharmacies
    • NAPC Practice Innovation Network
    •  
 
What is the intellectual property status of your innovation?:
We own the IP on all our content
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Dominic Arkwright 26/09/2016 - 16:02 Publish 1 comment
5
1
Votes
-99999
Innovation 'Elevator Pitch':
Sensely Ask NHS mobile app offering is a virtual nurse, Olivia, who guides the patient through clinical triaging or long term condition monitoring. Integrated and working with the NHS workforce. 
Overview of Innovation:
'Ask NHS' powered by Sensely provides patients and clinicians with improved access to NHS 111 and their local NHS services. Patients can talk through your symptoms in complete confidence with Nurse Olivia, a virtual nurse. If needed, Olivia she will arrange for a call back from a 111 Nurse to discuss symptoms further. Patients can also search NHS approved healthcare advice, schedule GP appointments and search opening times/locations of local healthcare services. It's the link for improving patient experience with Healthcare Providers and helping to cope with patient demand. Our key value proposition is to automate tasks for providers. We are Trusted , Empathetic, Personalised, Mobile First.

Sensely offers

- Mobile application platform that engages in natural conversations with patients.
- A clinician facing product which is data and process driven patient risk assessment.
- Direct Appointment Booking with GPs
- Service Locator (Integration with the NHS Directory of Services)
- Self Care Advice. Easily search through trusted NHS Choices healthcare advice and resources to gain a deeper understanding of conditions and treatments.
- Triage and Integration with Clinical Hubs (inc. NHS 111)
- Chronic Disease Management (CHF, COPD, Diabetes)

Olivia, our virtual nurse is connected with patients - 24/7 via their mobile device. She can help by answering their medical questions , measure their blood pressure, weight or glucose via blue tooth device, take a picture of their rash or swollen ankles and ask triage questions integrating with primary care services.

Olivia has been designed to embody the bedside manner of real healthcare professionals, and to be the clinician’s presence in patient’s life 24/7. Most importantly she does not only act as your virtual nurse - collecting vitals, scheduling appointments, offering health and wellness advice - she acts as your constant stream of accurate and clinically triaged information.

'Ask NHS' is powered by Sensely and delivered in collaboration with the NHS, NHS 111 and Odyssey by Advanced Healthcare. Visit http://www.sensely.com/asknhs to learn more.

For more information visit : http://www.asknhs.co.uk/ or email us at nhs@sensely.com
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Key Benefits

1) Saving the Clinician time. Pre Appointment Triage / Screening of patients, helping to prioritise those who need to be seen urgently - acting as admission avoidance tool. Sensely also offers the ability to directly book / cancel appointments into EMIS Web practices helping users to make an appointment when needed. Sensely supports CCGs achieve patient online programme initiatives through collaborative working we're providing the complete solution - one bundled app to navigate UK healthcare.

2) Improve health data. Using data captured through wearables. Sensely helps capture data and readings e.g blood pressure and weight measurements which can be subsequently filed to the GP patient record. Through the use of GPSoC APIs - data is recorded in a standard format using Readcodes ensuring high quality data capture and future analysis.

3) Using Sensely on smartphones provides clinicians with an ever-present clinical decision support tool that ensures they are providing patients with the best care plans.

4) Improved Patient Care - 24/7. Always available. Users can use the app to monitor their health and understand their body better. Subsequently, through Senselys integrated offering - the platform can alert a clinician when a patient who is being remotely monitored is flagged at being at risk. In the US - Sensely is used for supporting Chronic Care Management.

5) Improved efficiency to urgent care delivery. NHS 111 currently receives approx 30,000 calls per day. At an average of £13/call. This equates to £390,000 per day. Through the use of Sensely Artificial Nurse - we believe we can deal with a percentage of the self care queries / calls which are dealt with by a non clinical advisor (approx 20%) for which we could help save the NHS a potential of £78,000 per day.

6) Sensely interfaces with the Directory of Services which is utilised by NHS 111. Through the use of Service Locator - both clinicians and public can locate the right service at the right time. The tool ensures visibility of new services is transparent as possible to the right user. It is simple to use, accurate - always available tool where the content is locally administered by commissioning dos leads.
Initial Review Rating
4.20 (2 ratings)
Benefit to WM population:
To solve the health industry operational problems, we created Sense.ly. Sense.ly is a mobile-first application platform that engages in natural conversations with patients to educate them, assess their medical conditions, answer their questions, and find the best possible sources of virtual assistance, telemedicine, or facility assistance. Our technology gives health providers and insurance companies the power to tailor unique customizable communication protocols and interaction workflows for each patient. The product offers the following capabilities:

1. Provides patients with a high quality “mobile virtual assistant” that proactively and reactively engages people in natural, personalized conversations and educational topics depending on their status, historical, and current issues.

2. Continuous monitoring of patients via mobile app

3. Connects patient/provider/payers with secure telemedicine and SMS platform

4. Delivers clinical, educational, and NHS/CCG information directly to the patient based on daily clinical picture, stage of treatment, claim progress, and immediate needs

5. Analyzes health data to calculate clinical improvement, compliance, readmission risk, and patient engagement.

6. Analyzes data-aggregates across disparate populations for the purposes of machine learning, disease prevention, risk/cost management, and clinical trials. Doctors and specialist use the information Sense.ly provides to optimize their team’s workflow around patients requiring immediate attention, while freeing up resources that would otherwise be allocated to less demanding cases.
Current and planned activity: 
Concept/Idea (No prototype, wireframes): Prescription Ordering

Working prototype developed (gathering feedback): Service Locator, Self Care, Direct Appointment Booking

Prototype with pilot users/clinical trials (test/validating): NHS 111 Odyssey Assessment integration with NHS 111, Medication Check

Prototype with paying customers: Patient Kiosk, Daily Check In

Fully developed product (paying customers, renewing contracts): Chronic Care Management
What is the intellectual property status of your innovation?:
The IP include 7 patent applications allowing us freedom to continuing to operate and innovate on our products and service lines by refining
our proprietary avatar conversation engine and clinical decision support system. The IP includes code, methods, and integrations defining the
conversation engine.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Regulatory Approvals:
Please describe any current regulatory approvals you have achieved and how they were met/ in progress/planned.
Commercial information:
Please describe how the product/service is being developed commercially, whether in development, trials, pilot or full commercial delivery. Include the results you have from any market/demand surveys and forecasts . Please include any research you have on the broader commercial opportunity for the innovation both within the health sector nationally and internationally.
Investment activity:
Please describe what stage of investment you have reached and whether you are seeking additional rounds of investment. Please include cash investment as well as investment of soft assets such as access to specialist equipment, knowledge, trial base etc. and indicate the types/sources of your investment such as grants etc.
Regional Scalability:
Please describe how the innovation could be scaled across the WM region. Have you implemented at scale in any other regions?
Measures:
What outcomes are you hoping to achieve and what are the measures that you will use to gauge the success of the innovation and how will these assessments be made? Please ensure that you have quality, safety, cost and people measures.
Adoption target:
What are the targets for adoption across the WM and what are the minimum viability levels?
Investment sought:
What investment are you looking for in order to support wider adoption of this innovation and what have you managed to secure to date? Please provide a breakdown of these costs if possible.
Read more
Hide details
Anonymous 21/09/2016 - 14:58 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':

The NHS often does NOT know a patient’s wishes on treatment, their preferences or instructions. In a health emergency or mental crisis this information is vital.. MyDirectives gives everyone the chance to record their wishes in advance of a crisis.

Overview of Innovation:

MyDirectives.com and MyDirectives mobile gives every individual the opportunity to record their wishes for free. The service uses digitally delivered structured forms, video and audio messages to create high quality documents that health professionals trust to make best interest decisions. The service empowers individuals, allowing them to share their wishes with a close network of people (‘agents’) they trust to support them in a crisis or if they are unable to speak for themselves.  These ‘agents’ are sent instructional packs & urged to discuss preferences with the individuals concerned. MyDirectives then works with local health economies to integrate the person’s wishes & personal choices with primary, secondary and local authority databases & electronic health records so they can be confident their wishes & ‘digital voice’ will always be accessible & heard.
 
For health professionals this means they can be confident they are looking at the most up to date views of their patients, know who can speak for the patient & what their treatment choices & objectives are. This approach is both ‘human’ & from an innovation perspective, highly disruptive. It leads to faster, more appropriate & sensitive care decision making & can be easily scaled through MyDirectives' API to the whole care & health community.
 
The benefits of this pro-active approach are significant cash releasing savings that can be evidenced. An indication of how much this approach might save a health economy is a bill currently going though both houses of the US Congress that proposes to give every US citizen on Medicaid and Medicare £75 in return for creating a digital emergency, critical and advance care plan. MyDirectives has been live for four years and is used by individuals in 34 countries & is now looking for its first healthcare partner in the UK. 

We want a healthcare partner who can work with us to establish a UK integration network with GP suppliers, summary care record and organ donor lists and an adoption strategy using GP suppliers, secondary care providers, E-referrals, organ donor register and NHS Choices. We believe we can create a national system of adoption and retrieval using the NHS’ existing infrastructure. The end result will be a cost effective mechanism for recording and retrieving a patient's ‘voice’.

MyDirectives is the only company providing an integrated all digital solution to these issues.
 
See https://mydirectives for further details.

Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:

ADVault has created an economic model for England that shows for every £1 spent on MyDirectives a health authority would save between £1.77 to £9.33 within five years. The variation depends on which NHS England figures you apply to the model. Please see attached five case national economic model created for HM Treasury for full details. The models are based on targeting the entire adult population of a health economy and capturing 25% of all deaths.

If the NHS were to set a 50% adoption level and the capture of 25% of all deaths within five years as achievable targets, it could expect to generate net savings of between £64,916,693 to £702,791,693 per annum by the end of year five. A city such as Birmingham could therefore expect to save c£6m a year.

These cost savings can be realised as individuals express in their Emergency, Critical and Advance Care Plans (ECACP) their preferences, wishes and goals for treatment and care that permit the NHS to intervene more appropriately and less intensively.  As a result, ECACPs lead to fewer people dying in hospital, reduced admissions, achieve shorter hospital stays, reduced unnecessary ambulance journeys, fewer ‘heroic’ treatment measures and fewer incidences of distressing and unwanted life-sustaining treatments.
 
With an ECACP there is also compelling evidence that carers return to work sooner following family health crises and bereavements and experience fewer subsequent mental health issues, as the end of life events are managed more sympathetically.  Anecdotal evidence suggests even more significant savings following unexpected accidents and trauma where an ECACP is in place.

MyDirectives is supported by the National Council for Palliative Care (CEO Claire Henry); Baroness Finlay, the Chair of the National Mental Capacity Forum and Professor Bee Wee, the National Director for End of Life Care.

We are currently looking for our first NHS partner.

Initial Review Rating
4.40 (2 ratings)
Benefit to WM population:

In addition to the benefits described in the previous section, we are looking for a regional partner such as a GP group, Trust or STP to showcase and then spread this innovation across the wider NHS. We would be comfortable to enter into a commercial arrangement to facilitate this partnership.
 
If a suitable regional partner can be identified, we would consider locating our UK business Headquarters in the West Midlands.
 
Given the health economic forecast described previously and the predictive benefits model for saving to NHS England a city such as Birmingham could expect to save approximately £6m a year.

Current and planned activity: 

ADVault, creators of MyDirectives, is looking for its first UK integration partner. In the USA our integration business is now operating successfully in 10 US States. In addition, we are also in discussions with the Australian Federal government.

We are seeking a regional partner such as a GP group, Trust or STP to showcase the product and then to spread this innovation across the wider NHS community.
 
We would be comfortable to enter into a commercial arrangement to facilitate this partnership
 
Should suitable regional partners be found, we would consider locating our UK business headquarters within the West Midlands.

What is the intellectual property status of your innovation?:

All the intellectual property is owned by ADVault Inc

Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
3 years +
Ease of scalability: 
Simple
Regional Scalability:

MyDirectives can be scaled regionally or nationally. We generate better viral effects when we approach hundreds of thousands of people. This also "normalises" the process of recording you preferences, values and goals making success more likely. 

Measures:

Outcomes will be measured digitally based on volume of take up, retrieval and completion. We would also bring in researchers to look at impact on ambulance journeys, 111 decision making, medical crisis decision making, length of stay in hospital, organ donation rescind rate and deaths in normal place of residence.

Adoption target:

ADVault would seek to have 50% of a population signed up within five years. One of the consequence of this penetration would be that approx 25% of people in a community are likely to have one in place prior to a medical crisis.

Read more
Hide details
Jonathon Carr-Brown 27/07/2016 - 17:24 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Smartinhaler™ is an innovative electronic medication sensor that improves suboptimal medication use in patients with chronic respiratory diseases, including asthma and COPD. Our current focus is in asthma.
Overview of Innovation:
Poor medication adherence is one of the leading issues in the management of asthma and is thought to account for 34% of all asthma deaths (Royal College of Physicians, 2014) and treatment adherence to inhaled corticosteroids could reduce hospitalisation by 60% (Williams et al., 2004).
Smartinhaler™ (by Adherium Ltd) is a digital health solution to improve medication adherence in patients with chronic respiratory diseases. This is how it works: Smartinhaler™ clips onto an existing prescription inhaler. Once installed, the Smartinhaler™ device (1) periodically remind patients to take their medication, (2) records the date and time of inhaler use (independent of patient action), (3) transmits patient usage data to a mobile device and into Adherium’s cloud-based servers for patients and/or clinicians to review, and (4) provides warnings when the data indicate the patient’s disease may be escaping control.
The benefits of the Smartinhaler™ have been validated by independent clinical research. Four randomised controlled trials have shown consistent improvement in asthma medication adherence, ranging from 144% to 180% in children (Chan et al., 2015; Morton et al. 201X) and 33.3% to 58.7% in adults (Charles et al. 2007; Foster et al., 2014). Subsequently, the three studies measuring clinical outcome have demonstrated improved patient health as indicated by a reduction in oral corticosteroid use, reliever medication use, emergency room visits, lost school days and asthma morbidity score (Foster et al., 2014; Chan et al., 2015; Morton et al., 201X).
Audiovisual reminders markedly improve adherence to inhaled corticosteroids and thus increase health outcomes, whilst tracking reliever use may allow early detection of severe exacerbations (Patel et al., 2015). Furthermore, the objective nature of electronic adherence data enables an open and honest discussion about adherence and the barriers encountered by the patient. In turn, through HCP (or parental) intervention, this results in practical solutions to better manage asthma and or COPD.
The Smartinhaler™ platform was designed with patients in mind. In the development of the Smartinhaler, we’ve consulted patients and medical professionals to produce a user-centred system that facilitates good medical practice as well as empowering the patient.
For a list of references please visit our website: http://www.smartinhaler.com/outcomes/
 
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Potential reduction in mortality, hospital admissions, hospitalisations and A&E visits: Asthma accounts for approximately 60,000 hospital admissions and 200,000 bed days a year, with many others visiting A&E clinics without stay, uncontrolled asthma places a significant burden on NHS (British Lung Foundation, 2016). Williams et al. (2004) suggest adherence to inhaled corticosteroids could reduce hospitalisation by 60%. Given Smartinhaler’s ability to significantly and consistently improve adherence, it is expected that implementation of Smartinhalers™ will reduce the burden on the health services and most importantly improve the quality of life for asthmatics.
Potential reduction in medication wastage: In the UK, more than £230 million worth of asthma medicines are returned to pharmacies every year with a significantly larger proportion thought to be disposed by the patients themselves (Horne, 2006). Smartinhalers™ may reduce this wastage by improving treatment adherence as well as facilitating an open discussion about treatment between the clinicians, parents and patients.
Currently, the only similar technology implemented by some NHS funded hospitals is Florence – a telehealth application that connects patient data to healthcare professionals and text messaging to encourage positive behavioural change in patients with chronic illnesses. Although medication reminders can be sent to the phone, it appears text message reminders are less effective than direct device reminders (such as those in the Smartinhaler™) (Strandbygaard et al. 2010; Petrie et al. 2012). Furthermore, objective data about medication adherence cannot be collected using Florence and thus does not allow data-based clinical decisions for asthma. To our knowledge, there is no similar or equivalent technology used in current NHS practice specific for asthma. Standard physician care, asthma action sheets and for children, parental care, is the extent to which asthma medication adherence is addressed by the NHS. The Smartinhaler™ device would work alongside the current systems, used as an additional tool to improve the health of asthmatics, seamlessly integrating with current NHS practice.  
 
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Asthma is a major health issue in West Midlands. West Midlands (and South East) had the highest mortality rate for asthma. Furthermore, West Midlands has one of the highest asthma-related hospital admissions in England; in 2008-12, West Midlands was considered one of the worst five regions of England for asthma related admissions; other regions included North East, North West, and Yorkshire and the Humber (British Lung Foundation, 2016). Asthma not only influences health, it is associated with significant cost to society including work and school absenteeism as well as loss of productivity while at work (Bahadori et al. 2009).  
Taken together, introducing innovative and cost-effective digital health solutions is pivotal to the improvement of the health of West Midland’s asthmatics in increasing the quality of life, reducing burden on health services, and increasing economic productivity. As such, the implementation of Smartinhalers™ is a step forward for West Midlands health care system to alleviate the burden of asthma. 
REFERENCES
Bahadori et al. (2009). Economic burden of asthma: a systematic review. BMC pulmonary medicine, 9(1), 1.
British Lung Foundation (2016). Retrieved from https://statistics.blf.org.uk/asthma
Current and planned activity: 
  • Expansion of clinical data: several large and small clinical trials using Smartinhalers in asthma and COPD are on-going or in the prepublication stage. We expect more clinical trial results to be published this year and in the years ahead.
  • Development of new devices and further improvement of existing devices
  • Further improve patient-centred design of the Smartinhaler’s user interface
  • Expansion of global regulatory approvals
What is the intellectual property status of your innovation?:

Adherium has various patent protection in numerous jurisdictions. Furthermore, we hold numerous trademarks and registered design rights for our Smartinhaler™ range.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
3
Read more
Hide details
John Tarplee 05/07/2016 - 12:03 Publish 2 comments
5.5
2
Votes
-99999
Innovation 'Elevator Pitch':
Lilie EPR captures outpatient activity, diagnoses and treatments for GUM patients, provides the team shared access to patient records enabling instant communication between the service, lab and patient; reducing costs with efficient data management.
Overview of Innovation:
Leading the way  in the Management of Sexual Health Services
The modern day sexual health service challenges are significant. Public Health England (PHE) indicate that there were 446,253 sexually transmitted infections diagnosed in England in 2013 with Chlamydia being the most common, making up 47 per cent of all diagnosed cases. The most expensive cost to the NHS is HIV Infection, each new case of HIV infection is estimated to represent between £280,000 & £360,000 in lifetime treatment costs. Although the fall in teenage pregnancy is one of the success stories of the last decade in the public health field. However there is always room for improvement especially with more sexually active young people.
 
Lilie provides Sexual Health clinics and HIV services with a comprehensive Sexual Health computer software solution. Lilie is a fully scalable Electronic Patient Record system (EPR) used to capture outpatient activity, referrals, diagnoses and treatments for genitourinary medicine (GUM) patients. Having all the patients’ data in one EPR system provides all the clinic team members with fast access to patient data greatly reducing administration functions. All audit and quality measures are incorporated automatically reducing clinical risks and improving the quality of sexual health services.

Lilie’s core is the base application which is a totally secure full EPR system with comprehensive patient communication, statutory reporting i.e. HARS, SRHAD and GUMCAD, adhoc report generation. Additional modules to the core system can be purchased allowing the client to meet their budgetary requirements. Additional modules include: Contraceptive & Reproductive Health which is a secure and efficient way to manage Contraceptive and Reproductive Health data and services/ Chlamydia Screening providing exceptional NCSP data capture and reporting facilities/ Prescribing which includes the Dictionary of Medicines and Devices (DM+D)/ SMS Texting is an effective way to improve patient communications and reduce DNA rates/ Touchscreen allows the patient to announce their arrival in clinic and discretely enter personal data/ Internet Booking to empower your patients with time-saving, secure appointment management/ Lab Communications for fast and secure ways to order laboratory tests and receive results/ Collect for collecting patient data using mobile devices within an outreach environment.


For more information visit http://6pmsolutions.com/products/clinical/lilie
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Improves Productivity
Lilie is intuitive and easy to use allowing clinicians to spend more quality time with patients whilst allowing clinics to reduce appointment, management and reporting times. By default, the patients’ previous responses to questions are automatically populated hence saving clinic time and improving patient care.

Speeds up data collection.
The patient data you collect during your general working day is input into the electronic patient record (EPR) easily. The software and the dynamic screens change, validate and evolve as you enter this data.   

Reduces DNA’s
Lilie Online Internet Booking offers patients a discreet, more convenient and alternative route to treatment without staff intervention reduces management costs.  Lilie discrete SMS Text messaging will send out appointment reminders giving the patient the ability to confirm or cancel an appointment, freeing up slots for other patients.


Ensures clinical safety and maximises patient convenience.  
Lilie displays a patient banner across the top of the screen displaying key patient information, ensuring clinical safety whilst speeding up the clinic consultation.

Intuitive and easy to use. 
Lilie allows clinics to be more flexible according to their own services requirements. The consultation screens are easy to use and patient data can be easily collected. Lilie is so intuitive, you will reduce your training needs.

Ensures accurate recording of data. 
Data is input during the consultation whilst ensuring the right questions are asked at the right time, reducing and removing transcription errors. Thus written notes and illegible hand writing are a thing of the past.  

Accessible anywhere.
Lilie is available on a web based N3 platform and the cloud allowing access to different users over the Internet. This ensures improved availability, no costly client installations and access from any trust computer or device.

Simplified deployment, maintenance and painless upgrades.
The Lilie hosted solution can be deployed quickly and easily since no client terminal installation is required. Drastically reducing the initial investment in IT infrastructure.
The hosted solution ensures software updates and backups are carried out “behind the scenes”, reducing the costs associated with client installations and reducing the involvement of IT department resources.  This also means that when the number of users increase, no further investment in hardware, bandwidth or resources is required.
 
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
The Best outcomes for people and for populations depend on effective collaboration and cooperation. We can get there faster with Lilie’s integrated working tools.

Nationally, around four million people per year use NHS contraception services. The number of visits to genito-urinary medicine (GUM) clinics has doubled over the last decade and now stands at over a million a year.  The economic climate and pressure on resources are encouraging everyone to explore new approaches and opportunities that can deliver better outcomes and better value. The fields of sexual health, sexually transmitted infection (STI), contraception, reproductive health and HIV are frequently talked about as a whole service, yet each is separate and has its own defining features. Different elements have different commissioning arrangements which add to the complexity.

Lilie EPR for sexual health has been designed specifically to support multi-disciplinary teams treating sexual health and HIV. This “whole system” approach makes sense to the service user, the community and the commissioner. Having patient data in an EPR system provides all clinic team members with fast access to patient records, greatly reducing administration functions. Unlike paper records, patient data can be accessed from any Trusts computer enabling more than one healthcare professional to access the same record at the same time.  Patients’ needs for integrated pathways are at the heart of the case for whole system commissioning. Poorly connected care increases the risk of service users falling out of the system which can reduce their treatment adherence and worsen subsequent health outcomes. Disjointed pathways also result in missed opportunities to address people’s wider needs.

‘Lilie is a complete comprehensive software system that manages; Sexual Health, Contraceptive, HIV and Reproductive Health services.  There is also a separate module for contraception, so as to provide ‘Services’ with a choice of modules depending on their requirements.’

Greater adoption of this technology would also allow our company to develop additional modules for this system, as well as expand our team here in the region.

Lilie is the market leading Sexual health software in the UK
Current and planned activity: 
Lilie is constantly being evaluated to ensure it meets the demands of the users.  The software roadmap is ever evolving and this is helped by the Lilie User groups where nearly 200 users attend annually.

A new version of Lilie is being released where dynamic forms will feature heavily.  For more information contact lilie@6pmplc.com.



Planned / required activity 
  • Procurement / Adoption: -  We would like to see greater regional adoption of our Lilie and integrated suites of products and modules
  • Trials - We are interested in discussing opportunities with Trusts for additional trials, evaluation and validation of our system 
What is the intellectual property status of your innovation?:
Lilie is owned by 6pm Group.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
2
Read more
Hide details
Joanne Shrimpton 16/06/2016 - 15:34 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
The On Call Room is a social network for medical professional providing a platform to connect the best  medical/healthcare minds from around the world so they can share, learn and collaborate; progressing medicine.
Overview of Innovation:
The On Call Room is the free social network for healthcare professionals. Readily available on Google Play and the App Store, The On Call Room has registered users from 11 different countries around the world. With users using the platform to educate, inform and collaborate with one another, The On Call Room is a growing global community of healthcare professionals. From doctors - nurses, medical students - “Pre-reg” pharmacists, anaesthesiologists - geriatricians The On Call Room is a place to bring all these specialists together.
Being ISO27001 and HIPAA compliant, The On Call Room provides a safe, secure environment outside of commercial networks such as Facebook and Linkedin in which medical professionals can collaborate. Designed by medical professionals for medical professionals, The On Call Room has tools in place to facilitate the privacy and confidentiality of both medical professionals and patients, without stifling the progression of research or medical education.
The On Call Room is here to facilitate the already growing use of digital tool in healthcare, providing a reduced risk environment where healthcare professionals can share medical learning and innovations with other professionals not just in the user’s locality but also the world.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Education, training and future workforce / Digital health / Innovation and adoption / Patient and medicines safety
Benefit to NHS:
The On Call Room is a mobile application free at the point of use; with no implementation fees or sign up fees to any healthcare organisation.
The benefits The On Call Room has for the NHS is in the value of knowledge transfer. With the shortage of medical professionals in the UK* and many experienced staff soon retiring, we must ensure our current practising and the new up and coming healthcare practitioners are provided with every opportunity and resource to learn from the best medical minds from around the world and The On Call Room is a means of facilitating this.
Building on an already rigorous rigmarole of training required to be a healthcare professional, The On Call Room is a place to make knowledge relevant and plug any knowledge gaps an individual may have as our active community aids and assists each other to create an open repository of collaborative knowledge.
As we continue to grow our community both nationally and internationally The On Call Room will be a vibrant environment where a proven transformative practice can be shared and adopted at scale. An example of this is The Royal Free Hospital’s, Dr Sam Hare’s Heimlich valve management of iatrogenic pneumothorax, which has been shared on our platform and viewed by our  users around the world, sharing a new method to reduce hospital stay in patients after lung biopsies.
Being a digital innovation The On Call Room removes physical knowledge boundaries, such as locality and provides all thoses who sign up access to see the best innovations our community has to offer, providing them with a platform in which they can embetter themselves as professionals if they so choose.
*UK Government Shortage Occupation list, pages: 6, 7 and 13. See supplement documents
Initial Review Rating
1.80 (2 ratings)
Benefit to WM population:
With three medical schools in the West Midlands region, The University of Birmingham, The University of Warwick and Keele University, and a renown teaching hospital, Queen Elizabeth Hospital Birmingham, The On Call Room could be a prime educational resource to connect all those in training to the wider medical world, providing them with even more exposure in addition to their placement years.
For the wider population of the West Midlands, The On Call Room is here to facilitate the embetterment of healthcare professionals and the more they know the more adept they can be in their jobs, benefitting the wider community as a whole.
Current and planned activity: 
Internationally the team is currently onboarding healthcare professionals from India and all the healthare professionals from the country of Nepal.
In the UK we are in communication with Addenbrooke’s, a Cambridge University Hospital to onboard them to The On Call Room and other applications.
After engaging Milton Keynes University Hospital, London South Bank University and The University of Buckingham Medical School in our beta and now onboarding various Medical Societies across the country such as King’s College London MedTech Society our plan is to engage with as many healthcare professionals as we can across the country.
Support Requirements:
Helping ensure we are NHS Information Governance compliant to add to our ISO27001 and HIPAA compliance certifications.
What is the intellectual property status of your innovation?:
Medic Creations, The On Call Room's parent company are the sole owners of the On Call Room's intellectual property.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details
Akil Benjamin 09/06/2016 - 19:10 Publish Login or Register to post comments
4
1
Votes
-99999
Innovation 'Elevator Pitch':
We have a fully developed managed service ready to provide connectivity to mobile screening vans; automatically wirelessly transfer images to hospital PACS; remove outdated paper based processes and transform the metrics of breast screening.
Overview of Innovation:
For 25 years mobile breast screening vans have operated in isolation from Hospital HQs. Every day hard drives full of patient images are transported by taxi, courier, or most commonly fully trained radiographers between the van and hospital. Appointment lists are closed well in advance to allow them to be physically transported to the van and they are therefore outdated by the time they arrive. Clinical and administrative notes are made on paper which is also physically transported before the notes are transcribed into application software. Targeted turnaround time between screening and result has been 14 days for over 25 years.

​Our managed service revolutionises this process and can reduce the steps involved from 42 to 21.

​We transmit images directly from the van to hospital PACS in as little as three minutes. We make appointment systems live on the van and synchronise them with HQ. We create access to clinical applications so that all notes can be entered directly at point of need. We provide on board access to email, internet and intranet which has never been provided before.

​We give the HQ real time visibility to the van enabling them for the first time ever to see that staff have arrived safely and that screening has commenced on time. Our service can transform the metrics of screening and open the doors to radical overhaul of efficiencies and turn around times for results. We can remove all paper based systems and transform the reading and reporting process.

​All of these things can be achieved to deliver a better working environment, more efficiency, greater flexibility, better data accuracy and much improved data security and could normally be funded by cost savings that the service itself will generate.

We need help to accelerate the pace of adoption.
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Wellness and prevention of illness / Digital health / Innovation and adoption
Benefit to NHS:
  • Improved throughput on existing capital equipment
  • More flexible service at point of need
  • Improved accuracy by removing transcription errors
  • Better working conditions for radiology staff
  • Reduced risk of data loss
  • Improved management information
  • Better work processes
  • Removal of paper based processes
  • Opportunity to reduce the anxious waiting period between screening and results
Initial Review Rating
3.40 (1 ratings)
Benefit to WM population:
The Breast Screening Programme (BSP) is one of the largest and most important screeniong programmes in the UK. The benefits of regular screening, early detection, and faster treatment are well proven and documented. Our service enables operators of the programme to bring their service into the 21st Century. The benefits shown above are extensive and far reaching and would impact directly in the service provided to the women of the West Midlands who would find the service more flexible, more accurate and more secure.
Current and planned activity: 
Two mobile vans operated by UHB are already contracted to our service. We now need to expand to the other operators in the West Midlands. We have a fully developed demonstration trailer that we can bring to any site. It would be great to have a fully documented case study on our service anda way into becoming an appproved supplier to the NHS. We need help.
What is the intellectual property status of your innovation?:
We need to investigate the potential for IP in our software.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
David Osmond 01/06/2016 - 19:08 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':

Using simple technology, we enable care homes to coordinate the monitoring of vital signs, weight and hydration acting as an early warning system with direct integration into GP systems.

Overview of Innovation:

Inhealthcare have developed a Digital Care Home service, which coordinates the monitoring of vital signs, weight and hydration. It acts as an early warning system, highlighting changes in health which may otherwise go undetected. Their service includes a digital patient record which integrates directly with GP systems, meaning that it can be accessed by local NHS teams.

Our digital health services are in place in over 80 care homes in the UK, helping care home managers and nurses carry out frequent checks on residents.

Find out how it works on our website http://www.inhealthcare.co.uk/digital-health-solutions/care-homes/.

You can also read a blog from Georgia Nelson about a pilot of our Digital Care Home in 14 care homes in Northern Irealand http://www.inhealthcare.co.uk/telehealth-undernutrition-service-care-homes-northern-ireland/.

Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
  1. Reduces non-elective admissions through detecting deteriorating health early on
  2. Improves co-ordination between the NHS and the care home through better sharing of information with GP system integration
  3. Supports early hospital discharge by giving clinicians more confidence that needs will be met in the care home
  4. Improves the visibility of residents’ health, meaning community nurses can better monitor patients without the need for travel
  5. Improves compliance around care
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:

1. Enhanced monitoring of residents, enabling early detection of health deterioration enabling timely intervention.

Current and planned activity: 

Our digital health services are in place in over 80 care homes in the UK, helping care home managers and nurses carry out frequent checks on residents.
 

Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
N/A
Ease of scalability: 
Simple
Read more
Hide details
Lauren Ramsey 24/05/2016 - 14:41 Publish Login or Register to post comments
3
1
Votes
-99999
Innovation 'Elevator Pitch':
We have developed a clinically led digital health solution for warfarin patients at risk of stroke. Our technology enables patients to self-test from their own homes with remote clinical support, communicating their INR in a way that suits them.
Overview of Innovation:
Our INR self-testing service has been rolled out to 5,000 patients, making it one of the largest in Europe. Across the UK, patients on the service are remotely monitoring their INR away from the clinic using a Roche CoaguChek® device. Readings are sent to their nurse via an automated phone call or by logging onto an online portal. Readings automatically go through anticoagulation software where the next dose is determined. A clinician approves the next dose and the patient receives a second form of communication, either an automated phone call or an email informing them of their next warfarin dose and date and time of next test. Find out more here http://www.inhealthcare.co.uk/product/inr-self-testing/.
Our self-testing study concluded patient’s therapeutic range (TTR) improved by 20% for 70% of patients. In comparison a controlled cohort of clinic based patients had seen only 49% of their cohort improve by an average of 2%.This improved TTR predicts to save 400-500 strokes per year.” – Ian Briggs, Associate Director of Business Development, County Durham and Darlington Foundation Trust.

To find out more about INR self-testing in County Durham and Darlington Foundation Trust download our case study here http://www.inhealthcare.co.uk/resource/county-durham-and-darlington-nhs-foundation-trust/.

The service has also been rolled out in Wigan, Ilkley and the Isle of Wight. Read this blog from our CEO Bryn Sage about INR self-testing in the Isle of Wight http://www.inhealthcare.co.uk/isle-of-wight-are-leading-the-way-with-inr-self-testing-for-warfarin-patients/.

Outcomes:
  1. Improved patient outcomes: In a recent 24 month follow up study from County Durham and Darlington Foundation Trust we found over 70% of those on the service improved their time in therapeutic range by 20%.
  2. Improved patient satisfaction: The service is quick and easy to use. Patients do not have to take time out of their day to attend appointments and aren't bound to NHS opening hours. 100% of those surveyed said they'd recommend the service to others.
  3. Increased efficiency: Enabling patients to self-test enables resources to be distributed elsewhere.

 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
  • Reduced workload
  • Increased capacity
  • Cost savings
  • Able to spend more quality time with patients that need to attend the clinic
  • Access to real time patient data
  • Able to identify any adversities and make changes in treatment much sooner
  • Able to make informed decisions around patient care
  • Choice of communication method to suit their patients
Initial Review Rating
5.00 (3 ratings)
Benefit to WM population:
  • More flexibility for patients
  • Improve clinical outcomes
  • Not bound to NHS opening hours
  • Able to find out more around condition
  • Less clinic visits and associated costs
  • Technology is quick and easy to use
  • Clinicians have access to a continuum of data meaning patients don’t have to repeat themselves during appointments
Current and planned activity: 
We are currently working with a number of NHS organisations that have implemented our INR self-testing service including County Durham and Darlington NHS Foundation Trust, Wigan Borough Federated Healthcare, Isle of Wight CCG, Ilkley Moor GP practices.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
N/A
Ease of scalability: 
Simple
Read more
Hide details
Lauren Ramsey 24/05/2016 - 14:20 Publish Login or Register to post comments
5
1
Votes
-99999
Innovation 'Elevator Pitch':
Do you wan to improve outcomes and gather PROMs in MSK or Pain Management:

Improving Outcome and Making Saving of 15 % admitted care costs
Digital Assessments for PROMS
Self Assessment / Management of Chonic Pain.
​12 Tools for Self Management
CBT
Overview of Innovation:
https://www.youtube.com/watch?v=r_qVLCmv4JM

​PainSense ( www.pain-sense.co.uk) is two digital apps, designed to give more support for self-management for people living with persistent pain. The resources include an app version of the "Pain Toolkit" developed by Dr Frances Cole and Pete Moore, and an app version of the "Pain Management Plan" developed by Dr Cole and Professor Bob Lewin, as well as a set of app-based needs assessment and patient-reported outcome tools, and eLearning resources for clinicians. The apps can be integrated into clinical systems such as SystmOne and EMIS or accessed on a secure portal.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Health Economics – Leeds ( July 2016 )
•Increase in the number of patients entering the pathway in the 11months for which we have comparable data – exact numbers to be confirmed.
•Annualised saving in total cost of pathway of c£280,000 representing a 9% reduction in total pathway spend of £2.9million
•Switch from 58% of 1st OPs being seen in acute trusts, to 29%, representing substantial transfer of care to community sector. This trend is expected to continue still further
•Reduction in hospital in patient and day case procedures of 6% with an associated cost reduction of 15%, indicating fewer and lower complexity medical pain interventions
•Substantial improvement in patient reported outcomes. Sample patient reported data from 216 discharged patients from our key community provider has demonstrated an average 27.5% reduction in the level and extent of their pain (using DOLO scoring) and a 34% improvement in their confidence and ability to cope with their pain (Using PSEQ). On their Friends and Family test outcomes, of 119 patients 66% responded that they would be extremely likely, and a further 29% likely to recommend the service to their friends and family - an overall positive response of 95%.
We have previous figures re Opioid reduction in pilot sites.
Initial Review Rating
3.20 (2 ratings)
Benefit to WM population:
Improving Self Care - Self Managment Skills
Improving Health Function - Data form FrCole.


 
Current and planned activity: 
We are keen to roll out the PainSense Service across the UK, we have already engaged with several CCG but are keen to work with other from as early as pre tender and or service redesign stage.

SWBH is already using PainSense in the West Midlands and we are keen for more sites so please do get in touch.
 
What is the intellectual property status of your innovation?:
IP is with ADI, PainToolKit and PMP, registered.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Keli Shipley 11/05/2016 - 19:21 Publish Login or Register to post comments
0
0
Votes
-99999

Active Campaigns